FR1538322A - Procédé de préparation d'une suspension virale inactivée - Google Patents

Procédé de préparation d'une suspension virale inactivée

Info

Publication number
FR1538322A
FR1538322A FR84337A FR84337A FR1538322A FR 1538322 A FR1538322 A FR 1538322A FR 84337 A FR84337 A FR 84337A FR 84337 A FR84337 A FR 84337A FR 1538322 A FR1538322 A FR 1538322A
Authority
FR
France
Prior art keywords
preparing
viral suspension
inactivated viral
inactivated
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR84337A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc SA
Original Assignee
Rhone Poulenc SA
Societe des Usines Chimiques Rhone Poulenc SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc SA, Societe des Usines Chimiques Rhone Poulenc SA filed Critical Rhone Poulenc SA
Priority to FR84337A priority Critical patent/FR1538322A/fr
Priority to NL6715369A priority patent/NL6715369A/xx
Priority to GR670133293A priority patent/GR33293B/el
Priority to BE706781D priority patent/BE706781A/xx
Priority to US684540A priority patent/US3655871A/en
Priority to YU2268/67A priority patent/YU31920B/xx
Priority to IL28977A priority patent/IL28977A/en
Priority to SE15924/67A priority patent/SE365542B/xx
Priority to GB52684/67A priority patent/GB1183506A/en
Priority to DK579067AA priority patent/DK117316B/da
Priority to FI3119/67A priority patent/FI43766B/fi
Priority to DE19671617779 priority patent/DE1617779A1/de
Priority to CH1626667A priority patent/CH477552A/fr
Priority to AT1049667A priority patent/AT275733B/de
Priority to ES347412A priority patent/ES347412A1/es
Application granted granted Critical
Publication of FR1538322A publication Critical patent/FR1538322A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
FR84337A 1966-11-21 1966-11-21 Procédé de préparation d'une suspension virale inactivée Expired FR1538322A (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR84337A FR1538322A (fr) 1966-11-21 1966-11-21 Procédé de préparation d'une suspension virale inactivée
NL6715369A NL6715369A (fr) 1966-11-21 1967-11-13
GR670133293A GR33293B (el) 1966-11-21 1967-11-18 Μεθοδος παρασκευης νεων εμβολιων κατα της γριππης.
SE15924/67A SE365542B (fr) 1966-11-21 1967-11-20
YU2268/67A YU31920B (en) 1966-11-21 1967-11-20 Postupak za spravljanje monovalentnih ili polivalentnih vakcina protiv gripa
IL28977A IL28977A (en) 1966-11-21 1967-11-20 New vaccines for combating influenza and the preparation thereof
BE706781D BE706781A (fr) 1966-11-21 1967-11-20
GB52684/67A GB1183506A (en) 1966-11-21 1967-11-20 New vaccines for combating influenza and the preparation thereof
DK579067AA DK117316B (da) 1966-11-21 1967-11-20 Fremgangsmåde til fremstilling af mono- eller polyfunktionelle vacciner mod human-, heste-, svine- eller fugleinfluenzavirus.
FI3119/67A FI43766B (fr) 1966-11-21 1967-11-20
US684540A US3655871A (en) 1966-11-21 1967-11-20 Inactivation of influenza viruses with lower alkyl esters of acetic acid
CH1626667A CH477552A (fr) 1966-11-21 1967-11-21 Procédé de préparation de suspension virale inactivée de virus grippaux
DE19671617779 DE1617779A1 (de) 1966-11-21 1967-11-21 Neue Vaccinen gegen Grippe und ihre Herstellung
AT1049667A AT275733B (de) 1966-11-21 1967-11-21 Verfahren zur Herstellung von monovalenten oder polyvalenten Vaccinen
ES347412A ES347412A1 (es) 1966-11-21 1967-11-21 Procedimiento para la preparacion de una suspension viral inactivada monovalente o polivalente.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR84337A FR1538322A (fr) 1966-11-21 1966-11-21 Procédé de préparation d'une suspension virale inactivée

Publications (1)

Publication Number Publication Date
FR1538322A true FR1538322A (fr) 1968-09-06

Family

ID=8621311

Family Applications (1)

Application Number Title Priority Date Filing Date
FR84337A Expired FR1538322A (fr) 1966-11-21 1966-11-21 Procédé de préparation d'une suspension virale inactivée

Country Status (15)

Country Link
US (1) US3655871A (fr)
AT (1) AT275733B (fr)
BE (1) BE706781A (fr)
CH (1) CH477552A (fr)
DE (1) DE1617779A1 (fr)
DK (1) DK117316B (fr)
ES (1) ES347412A1 (fr)
FI (1) FI43766B (fr)
FR (1) FR1538322A (fr)
GB (1) GB1183506A (fr)
GR (1) GR33293B (fr)
IL (1) IL28977A (fr)
NL (1) NL6715369A (fr)
SE (1) SE365542B (fr)
YU (1) YU31920B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013106548A1 (fr) 2012-01-10 2013-07-18 The Broad Institute, Inc. Procédés et cellules pour la production de vaccins viraux

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158054A (en) 1973-10-18 1979-06-12 Duncan Flockhart & Co. Ltd. Preparation of virus sub-unit vaccines
US4000257A (en) * 1975-12-22 1976-12-28 American Cyanamid Company Process for the purification of influenza virus vaccine
USRE33164E (en) * 1979-05-15 1990-02-13 Mobay Corporation Influenza vaccine production in liquid cell culture
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
US5639461A (en) * 1994-09-30 1997-06-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Influenza machine
AU4161296A (en) * 1995-10-20 1997-05-07 Davidson, Clifford M. Influenza vaccine
AUPQ486699A0 (en) * 1999-12-23 2000-02-03 Aruba International Pty Ltd A method of treating infectious diseases
US20090017069A1 (en) 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US20090181362A1 (en) * 2005-09-02 2009-07-16 Yasuo Suzuki Method for determination of recognition specificity of virus for receptor sugar chain

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013106548A1 (fr) 2012-01-10 2013-07-18 The Broad Institute, Inc. Procédés et cellules pour la production de vaccins viraux

Also Published As

Publication number Publication date
NL6715369A (fr) 1968-05-22
YU31920B (en) 1974-02-28
YU226867A (en) 1973-08-31
CH477552A (fr) 1969-08-31
GB1183506A (en) 1970-03-11
ES347412A1 (es) 1969-01-16
DK117316B (da) 1970-04-13
FI43766B (fr) 1971-03-01
US3655871A (en) 1972-04-11
BE706781A (fr) 1968-05-20
AT275733B (de) 1969-11-10
DE1617779A1 (de) 1972-03-23
SE365542B (fr) 1974-03-25
IL28977A (en) 1972-05-30
GR33293B (el) 1967-11-21

Similar Documents

Publication Publication Date Title
FR1538322A (fr) Procédé de préparation d'une suspension virale inactivée
FR1513031A (fr) Procédé perfectionné de préparation d'aminonitriles
CH475285A (fr) Procédé de préparation d'organotrisiloxanes
CH509955A (fr) Procédé de préparation de l'hydroxycitronellal
FR1487354A (fr) Procédé de préparation d'hexadiènes
FR1507525A (fr) Procédé de préparation d'imino-dérivés de 5-nitro-(2)-furfurylidène
FR1522825A (fr) Procédé de préparation d'alpha-amino-alpha-méthyl-propionanilides
CH466386A (fr) Procédé de préparation d'une électrode
FR1482092A (fr) Procédé de préparation d'iodofluoroalcanes
FR1539369A (fr) Procédé de préparation d'une suspension
FR1501824A (fr) Procédé de préparation de l'alpha-méthyl-gamma-butyrolactone
CH473131A (fr) Procédé de préparation de phénazines substituées
FR96082E (fr) Procédé de préparation d'iodopentafluoroéthane.
FR1518386A (fr) Procédé de préparation d'aza-dioxa-bicyclo-alcanes
CH436571A (fr) Procédé de préparation de l'alanosine
FR1525622A (fr) Procédé de préparation de phénazines substituées
FR1374725A (fr) Procédé de préparation de l'orotidine
FR1454183A (fr) Procédé de préparation d'halogénures de carbonylhalogénosulfényle
FR1520906A (fr) Procédé de préparation de suspensions de copolymères styrène-butadiène
FR1491412A (fr) Procédé de préparation d'organotrisiloxanes
FR1470999A (fr) Procédé de préparation de ferrosilicium
FR1519102A (fr) Procédé de préparation de 5'-nucléotides
FR1541884A (fr) Procédé perfectionné de préparation de l'éthylauramine
FR1451443A (fr) Procédé de préparation de l'adiponitrile
FR1547872A (fr) Procédé de préparation d'isocyanurate glycidylique modifié